Existing vaccines have been developed mostly against ... by several orders of magnitude and making possible the selection of antigens that are conserved and that induce antibody-mediated protection.
Several observations point toward the possibility of a vaccine development strategy ... of most of these surface proteins has made antigen selection problematic. Obstacles to the development ...
Selection of 19 individual researchers among ... Cheever and colleagues establish a definition of 'ideal' antitumor vaccine antigens based on weighted criteria, including: evidence of antitumor ...
The approach builds off the current bivalent Human Hookworm Vaccine now in clinical development and would ultimately add both a larval Ascaris lumbricoides antigen and an adult-stage Trichuris ...
The Antigen Discovery and Molecular Biology Unit expresses and purifies recombinant protein antigens for vaccines against neglected tropical diseases and other emerging infectious diseases. The unit ...
The product line includes Neuraminidase (NA), Hemagglutinin (HA) and Nucleoprotein (NP) proteins, from all WHO-recommended vaccine strains in the past few years. Such antigens could be utilized to ...
TG4050 is an individualized immunotherapy being developed for solid tumours that is based on Transgene’s myvac platform and powered by NEC’s cutting-edge AI capabilities designed to optimize antigen ...